cyclohexanol has been researched along with gamma-aminobutyric acid in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (5.66) | 18.2507 |
| 2000's | 27 (50.94) | 29.6817 |
| 2010's | 23 (43.40) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosenberg, HC; Tersigni, TJ | 1 |
| Sañudo-Peña, MC; Walker, JM | 1 |
| Brown, ES; Hong, SC | 1 |
| Freund, TF; Hájos, N; Katona, I; Ledent, C; MacKie, K; Mody, I; Naiem, SS | 1 |
| Bockaert, J; Manzoni, OJ | 1 |
| Ballenger, JC | 1 |
| Acsady, L; Freund, TF; Hajos, N; Katona, I; Ledent, C; Mackie, K; Rancz, EA | 1 |
| Begg, M; Molleman, A; Parsons, M | 1 |
| Durkin, JP | 1 |
| de Miguel, R; De Petrocellis, L; Di Marzo, V; Fernández-Ruiz, J; Lastres-Becker, I; Makriyannis, A | 1 |
| Malek-Ahmadi, P | 1 |
| Alger, BE; Brager, DH; Erdélyi, F; Luther, PW; Szabó, G | 1 |
| Barton, D; Loprinzi, CL | 1 |
| Battista, N; Bernardi, G; Calabresi, P; Centonze, D; Finazzi-Agrò, A; Maccarrone, M; Mercuri, NB; Rossi, S | 1 |
| Bo-Hua, Z; He, L; Hong-Ju, Y; Jun-Wei, W; Nan, Z; Wei-Guo, S; Wei-Xiu, Y; Zhe-Hui, G; Zheng-Hua, G; Zhi-Pu, L; Zhong-Wei, J | 1 |
| Stearns, V | 1 |
| Hemrick-Luecke, SK; Iyengar, S; Simmons, RM; Webster, AA; Xu, JY | 1 |
| Cannizzaro, C; D'Amico, M; Martire, M; Preziosi, P | 1 |
| De Vry, J; Jentzsch, KR | 1 |
| Boulet, JM; Chaffer, SM; Elsemore, DA; Gottshall, SL; Harrison, JE; Koetzner, L; Lee, G; Mark, L; Miller, W; Pearson, MS; Rabadi, L; Rotshteyn, Y; Shan, S; Tafesse, L; Toth, M; Turchin, PI; Valenzano, KJ; Whiteside, GT | 1 |
| Ciraulo, DA; Hennen, J; Jensen, JE; Ke, Y; Knapp, C; Kwak, T; Meyer, AA; Nassar, LE; Renshaw, PF; Sarid-Segal, O; Streeter, CC | 1 |
| D'Souza, DN; Iyengar, S; Pritchett, YL; Raskin, J; Smith, TR; Wernicke, JF; Wong, K | 1 |
| Carchenilla, MS; Jacobsson, SO; Johansson, M; Persson, E; Svensson, AC | 1 |
| Birnbaum, HG; Gelwicks, S; Le, TK; Mareva, MN; Robinson, RL; Rosen, A; Wu, EQ | 1 |
| Bjerrum, OJ; Blackburn-Munro, G; Broløs, T; Rode, F | 1 |
| Kasper, S; Montgomery, SA; Pande, AC; Tobias, K; Zornberg, GL | 1 |
| Robinson-Papp, J; Simpson, DM | 1 |
| Barrot, M; Doridot, S; Freund-Mercier, MJ; Hein, L; Petit-Demoulière, N; Tessier, LH; Yalcin, I | 1 |
| Dukes, E; Mychaskiw, M; Oster, G; Rejas, J; Sofrygin, O; Vera-Llonch, M | 1 |
| Crystal, SC; Grosberg, BM; Hutchinson, S; Robbins, MS | 1 |
| Amr, YM; Yousef, AA | 1 |
| Bujoreanu, IS; DeMaso, DR; Ibeziako, P | 1 |
| Doherty, DA; Emery, LI; Gregson, J; Hickey, M; Saunders, CM | 1 |
| Bordeleau, L; Ennis, M; Goodwin, PJ; Haq, R; Jugovic, O; Loprinzi, CL; Pritchard, KI; Warr, D | 1 |
| Becker, A; Höllt, V; Schröder, H | 1 |
| Baldinetti, F; Bandelow, B; Herman, B; Kasper, S; Mandel, FS; Nivoli, G; Petralia, A; Van Ameringen, M | 1 |
| Baldwin, DS; Lyndon, G; Schweizer, E; Xu, Y | 1 |
| Almela, P; Aracil-Fernández, A; Manzanares, J | 1 |
| Horrillo, I; Martisova, E; Meana, JJ; Ortega, JE; Ramírez, MJ; Solas, M; Tordera, RM | 1 |
| Ambrosio, E; Assis, MA; Borcel, E; Coria, SM; del Olmo, N; Higuera-Matas, A; Miguéns, M | 1 |
| Knapp, LE; Miceli, JJ; Ramey, TS; Rickels, K; Shiovitz, TM; Weaver, JJ | 1 |
| Guttuso, T | 1 |
| Girbig, D; Igl, BW; Lehmann, T; Obendorf, M; Patchev, VK; Prelle, K | 1 |
| Bailey, JE; Craig, K; Dawson, GR; Diaper, A; Dourish, CT; Nutt, DJ; Osman-Hicks, V; Rich, AS | 1 |
| Lutz, B; Purrio, M; Rey, AA; Viveros, MP | 1 |
| Neher, JO; Sarkissian, A; Singh, R; St Anna, L | 1 |
| Bonanno, G; Bonifacino, T; Gabriel, C; Mallei, A; Milanese, M; Mocaer, E; Musazzi, L; Popoli, M; Racagni, G; Tardito, D; Treccani, G | 1 |
| Bailey, JE; Craig, K; Dawson, GR; Diaper, A; Dourish, CT; Nutt, DJ; Rich, AS; Wilson, SJ | 1 |
| Fujii, T; Kobayashi, D; Natori, A; Okajima, Y; Yamaguchi, N | 1 |
| Basnet, A; Bjerrum, OJ; Butler, M; Butler, S; Gordh, TE; Honoré, PH; Kristensen, K | 1 |
| Scheinfeld, N | 1 |
| Afshari, D; Baziyar, M; Bostani, A; Mahmoodi, M; Moradian, N; Razazian, N | 1 |
9 review(s) available for cyclohexanol and gamma-aminobutyric acid
| Article | Year |
|---|---|
Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Cyclohexanols; Drug Administration Schedule; gamma-Aminobutyric Acid; Humans; Monoamine Oxidase Inhibitors; Norepinephrine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Making sense of the evidence regarding nonhormonal treatments for hot flashes.
Topics: Acetates; Activities of Daily Living; Algorithms; Amines; Cyclohexanecarboxylic Acids; Cyclohexanols; Decision Trees; Drug Monitoring; Drug Therapy, Combination; Evidence-Based Medicine; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Menopause; Middle Aged; Nursing Assessment; Patient Selection; Quality of Life; Selective Serotonin Reuptake Inhibitors; Self Care; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Management of hot flashes in breast cancer survivors and men with prostate cancer.
Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Complementary Therapies; Contraceptives, Oral, Synthetic; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Male; Medroxyprogesterone; Menopause, Premature; Paroxetine; Prostatic Neoplasms; Quality of Life; Selective Serotonin Reuptake Inhibitors; Survivors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Safety profile of treatment in diabetic peripheral neuropathic pain.
Topics: Administration, Topical; Analgesics; Anesthetics, Local; Anticonvulsants; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Capsaicin; Cyclohexanols; Diabetic Neuropathies; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Pain; Pregabalin; Thiophenes; Venlafaxine Hydrochloride | 2007 |
Psychiatric concerns in pediatric epilepsy.
Topics: Adolescent; Amines; Anxiety Disorders; Bipolar Disorder; Child; Child, Preschool; Cyclohexanecarboxylic Acids; Cyclohexanols; Epilepsy; Gabapentin; gamma-Aminobutyric Acid; Humans; Mental Disorders; Norepinephrine; Pregabalin; Selective Serotonin Reuptake Inhibitors; Valproic Acid; Venlafaxine Hydrochloride; Young Adult | 2010 |
Effective and clinically meaningful non-hormonal hot flash therapies.
Topics: Actaea; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Cyclohexanols; Desvenlafaxine Succinate; Estrogen Replacement Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Glycine max; Hot Flashes; Humans; Isoflavones; Mandelic Acids; Menopause; Phytotherapy; Plant Extracts | 2012 |
Clinical Inquiry: Do venlafaxine and gabapentin control hot flashes in women with a history of breast cancer?
Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Constipation; Cyclohexanecarboxylic Acids; Cyclohexanols; Dizziness; Dose-Response Relationship, Drug; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Off-Label Use; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
The efficacy of nonestrogenic therapy to hot flashes in cancer patients under hormone manipulation therapy: a systematic review and meta-analysis.
Topics: Amines; Antineoplastic Agents, Hormonal; Cyclohexanecarboxylic Acids; Cyclohexanols; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Neoplasms, Hormone-Dependent; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Treatment of hidradenitis supprurativa associated pain with nonsteroidal anti-inflammatory drugs, acetaminophen, celecoxib, gabapentin, pegabalin, duloxetine, and venlafaxine.
Topics: Acetaminophen; Amines; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Hidradenitis Suppurativa; Humans; Pain; Pain Management; Pregabalin; Pyrazoles; Selective Serotonin Reuptake Inhibitors; Sulfonamides; Thiophenes; Venlafaxine Hydrochloride | 2013 |
13 trial(s) available for cyclohexanol and gamma-aminobutyric acid
| Article | Year |
|---|---|
Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Antioxidants; Benzothiazoles; Cocaine-Related Disorders; Cyclohexanols; Double-Blind Method; Female; gamma-Aminobutyric Acid; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nicotine; Pramipexole; Prefrontal Cortex; Protons; Retrospective Studies; Thiazoles; Time Factors; Venlafaxine Hydrochloride | 2005 |
Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.
Topics: Amines; Amitriptyline; Analysis of Variance; Cyclohexanecarboxylic Acids; Cyclohexanols; Diabetic Neuropathies; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
Topics: Adrenergic Uptake Inhibitors; Aged; Amines; Amitriptyline; Analgesia; Analgesics; Brain; Cohort Studies; Cost-Benefit Analysis; Cyclohexanecarboxylic Acids; Cyclohexanols; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Norepinephrine; Pain Measurement; Pain Threshold; Placebo Effect; Serotonin; Thiophenes; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2006 |
Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine.
Topics: Adult; Anticonvulsants; Anxiety Disorders; Cyclohexanols; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Placebos; Pregabalin; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain.
Topics: Acute Disease; Adult; Amines; Analgesics; Breast Neoplasms; Chronic Disease; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Mastectomy, Radical; Mastectomy, Segmental; Middle Aged; Morphine; Pain Measurement; Pain, Postoperative; Perioperative Care; Statistics, Nonparametric; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.
Topics: Amines; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Breast Neoplasms; Cross-Over Studies; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Middle Aged; Patient Preference; Surveys and Questionnaires; Survivors; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Norepinephrine; Patient Dropouts; Pregabalin; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2009 |
Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR?
Topics: Adult; Analgesics; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; gamma-Aminobutyric Acid; Humans; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Pregabalin; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Anxiety Disorders; Citalopram; Cyclohexanols; Double-Blind Method; Drug Therapy, Combination; Europe; Female; gamma-Aminobutyric Acid; Humans; Kaplan-Meier Estimate; Least-Squares Analysis; Linear Models; Male; Middle Aged; Odds Ratio; Paroxetine; Placebos; Pregabalin; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2012 |
Evaluation of the effects of venlafaxine and pregabalin on the carbon dioxide inhalation models of Generalised Anxiety Disorder and panic.
Topics: Administration, Inhalation; Adult; Anxiety Disorders; Blood Pressure; Carbon Dioxide; Cyclohexanols; Double-Blind Method; Female; gamma-Aminobutyric Acid; Heart Rate; Humans; Male; Panic; Pregabalin; Surveys and Questionnaires; Venlafaxine Hydrochloride; Young Adult | 2013 |
Changes in cardiovascular function after venlafaxine but not pregabalin in healthy volunteers: a double-blind, placebo-controlled study of orthostatic challenge, blood pressure and heart rate.
Topics: Adrenergic Uptake Inhibitors; Adult; Blood Pressure; Calcium Channel Blockers; Cyclohexanols; Double-Blind Method; Female; gamma-Aminobutyric Acid; Heart Rate; Humans; Male; Posture; Pregabalin; Venlafaxine Hydrochloride; Young Adult | 2013 |
Donepezil provides positive effects to patients treated with gabapentin for neuropathic pain: an exploratory study.
Topics: Adult; Aged; Algorithms; Amines; Analgesics; Cyclohexanecarboxylic Acids; Cyclohexanols; Donepezil; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Indans; Male; Middle Aged; Neuralgia; Neuroprotective Agents; Pain Measurement; Piperidines; Quality of Life; Sample Size; Venlafaxine Hydrochloride | 2014 |
Evaluation of the efficacy and safety of pregabalin, venlafaxine, and carbamazepine in patients with painful diabetic peripheral neuropathy. A randomized, double-blind trial.
Topics: Adult; Affect; Aged; Analgesics; Analgesics, Non-Narcotic; Carbamazepine; Cyclohexanols; Diabetic Neuropathies; Double-Blind Method; Female; Follow-Up Studies; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain Measurement; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sleep; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
31 other study(ies) available for cyclohexanol and gamma-aminobutyric acid
| Article | Year |
|---|---|
Local pressure application of cannabinoid agonists increases spontaneous activity of rat substantia nigra pars reticulata neurons without affecting response to iontophoretically-applied GABA.
Topics: Action Potentials; Analgesics; Analysis of Variance; Animals; Benzoxazines; Bicuculline; Cannabinoids; Cyclohexanols; gamma-Aminobutyric Acid; Iontophoresis; Male; Morpholines; Naphthalenes; Neurons; Piperidines; Pressure; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Substantia Nigra | 1996 |
A novel neurotransmitter system involved in the control of motor behavior by the basal ganglia.
Topics: Action Potentials; Analgesics; Animals; Basal Ganglia; Benzoxazines; Bicuculline; Cannabinoids; Cyclohexanols; Dopamine; Dopamine Agonists; Electrophysiology; GABA Antagonists; gamma-Aminobutyric Acid; Morpholines; Motor Neurons; Naphthalenes; Nerve Degeneration; Neurotransmitter Agents; Oxidopamine; Piperidines; Pyrazoles; Quinpirole; Rats; Rimonabant; Sympatholytics; Thalamic Nuclei | 1998 |
Antidepressant-induced bruxism successfully treated with gabapentin.
Topics: Acetates; Amines; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bruxism; Cyclohexanecarboxylic Acids; Cyclohexanols; Depression; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Venlafaxine Hydrochloride | 1999 |
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.
Topics: Action Potentials; Analgesics; Animals; Antibodies; Benzoxazines; Cannabinoids; Cyclohexanols; Electrophysiology; Epitopes; gamma-Aminobutyric Acid; Hippocampus; Interneurons; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Microscopy, Electron; Morpholines; Naphthalenes; Neural Inhibition; Neural Pathways; Periodicity; Piperidines; Presynaptic Terminals; Pyramidal Cells; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Synaptic Transmission | 2000 |
Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens.
Topics: Analgesics; Animals; Cannabinoids; Cyclohexanols; gamma-Aminobutyric Acid; Male; Mice; Mice, Inbred C57BL; Nucleus Accumbens; Receptors, Cannabinoid; Receptors, Drug; Synaptic Transmission | 2001 |
Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission.
Topics: Amygdala; Analgesics; Animals; Benzoxazines; Cannabinoid Receptor Modulators; Cannabinoids; Cholecystokinin; Cyclohexanols; gamma-Aminobutyric Acid; Interneurons; Male; Membrane Potentials; Mice; Mice, Knockout; Morpholines; Naphthalenes; Nerve Net; Neural Inhibition; Organ Specificity; Patch-Clamp Techniques; Presynaptic Terminals; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Receptors, GABA-A; Synaptic Transmission | 2001 |
Modulation of the release of endogenous gamma-aminobutyric acid by cannabinoids in the guinea pig ileum.
Topics: Animals; Arachidonic Acids; Cannabinoids; Cyclohexanols; Electric Stimulation; Endocannabinoids; gamma-Aminobutyric Acid; Guinea Pigs; Ileum; In Vitro Techniques; Muscle Contraction; Myenteric Plexus; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Drug; Receptors, GABA-B | 2002 |
Gabapentin in complicated school refusal.
Topics: Acetates; Adolescent; Amines; Comorbidity; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxyzine; Male; Mental Disorders; Phobic Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Treating hot flashes with drugs: an update.
Topics: Acetates; Amines; Anticonvulsants; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Clonidine; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Venlafaxine Hydrochloride | 2002 |
Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acids, Neutral; Animals; Arachidonic Acids; Basal Ganglia; Cannabinoid Receptor Modulators; Capsaicin; Corpus Striatum; Cyclohexanols; Disease Models, Animal; Dopamine; Endocannabinoids; gamma-Aminobutyric Acid; Huntington Disease; Hyperkinesis; Male; Motor Activity; Nitro Compounds; Palmitates; Piperidines; Propionates; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 2003 |
Gabapentin and posttraumatic stress disorder.
Topics: Acetates; Adult; Amines; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Cyclohexanecarboxylic Acids; Cyclohexanols; Depressive Disorder, Major; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2003 |
Regulation of exocytosis from single visualized GABAergic boutons in hippocampal slices.
Topics: Animals; Baclofen; Calcium Channels; Cyclohexanols; Electric Stimulation; Excitatory Postsynaptic Potentials; Exocytosis; Fluorescent Dyes; GABA Agonists; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Green Fluorescent Proteins; Hippocampus; In Vitro Techniques; Isoenzymes; Luminescent Proteins; Mice; Mice, Transgenic; Neural Inhibition; Patch-Clamp Techniques; Presynaptic Terminals; Pyridinium Compounds; Quaternary Ammonium Compounds; Rats; Recombinant Fusion Proteins | 2003 |
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amidohydrolases; Animals; Arachidonic Acids; Cerebral Cortex; Cocaine; Cyclohexanols; Dopamine Agonists; Dose-Response Relationship, Drug; Dronabinol; Electrophysiology; Endocannabinoids; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Neostriatum; Patch-Clamp Techniques; Polyunsaturated Alkamides; Quinpirole; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, Dopamine D2; Synaptic Transmission; Synaptosomes | 2004 |
Effect of gabapentin derivates on mechanical allodynia-like behaviour in a rat model of chronic sciatic constriction injury.
Topics: Amines; Animals; Chronic Disease; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal; Gabapentin; gamma-Aminobutyric Acid; Memantine; Pain; Pain Threshold; Pregabalin; Prodrugs; Rats; Sciatic Neuropathy; Structure-Activity Relationship; Venlafaxine Hydrochloride | 2004 |
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
Topics: Acute Disease; Amines; Amitriptyline; Animals; Conscious Sedation; Cyclohexanecarboxylic Acids; Cyclohexanols; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Methyltyrosines; Milnacipran; Neuromuscular Junction; Norepinephrine; p-Chloroamphetamine; Pain; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Inhibition by anandamide and synthetic cannabimimetics of the release of [3H]D-aspartate and [3H]GABA from synaptosomes isolated from the rat hippocampus.
Topics: Animals; Arachidonic Acids; Aspartic Acid; Calcium; Cannabinoid Receptor Agonists; Cannabinoids; Capsaicin; Cyclohexanols; Endocannabinoids; gamma-Aminobutyric Acid; Hippocampus; Kinetics; Male; Polyunsaturated Alkamides; Potassium; Rats; Rats, Wistar; Synaptosomes | 2004 |
Discriminative stimulus effects of the structurally novel cannabinoid CB1/CB2 receptor partial agonist BAY 59-3074 in the rat.
Topics: Alkanesulfonates; Amines; Amitriptyline; Animals; Baclofen; Behavior, Animal; Benzoxazines; Carbamazepine; Cyclohexanecarboxylic Acids; Cyclohexanols; Discrimination Learning; Dose-Response Relationship, Drug; Dronabinol; Gabapentin; gamma-Aminobutyric Acid; Indans; Male; Molecular Structure; Morphine; Morpholines; Naphthalenes; Nitriles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sulfonic Acids | 2004 |
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.
Topics: Amines; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anxiety; Ataxia; Behavior, Animal; Benzoxazines; Binding, Competitive; Catalepsy; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Immunosuppressive Agents; Indoles; Indomethacin; Inflammation; Male; Mice; Mice, Knockout; Morpholines; Naphthalenes; Pain; Pain Measurement; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Cannabinoid, CB2; Time Factors | 2005 |
Expression of functional CB1 cannabinoid receptors in retinoic acid-differentiated P19 embryonal carcinoma cells.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Benzoxazines; Blotting, Western; Calcium; Carcinoma; Cell Differentiation; Cell Line, Tumor; Cyclic AMP; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Embryo, Mammalian; Enzyme Inhibitors; gamma-Aminobutyric Acid; Gene Expression; Mice; Morpholines; Naphthalenes; Receptor, Cannabinoid, CB1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Temperature; Tretinoin; Tritium | 2006 |
Venlafaxine compromises the antinociceptive actions of gabapentin in rat models of neuropathic and persistent pain.
Topics: Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Cyclohexanols; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Kidney; Male; Neuralgia; Pain; Pain Measurement; Rats; Rats, Inbred BN; Venlafaxine Hydrochloride | 2006 |
Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amines; Animals; Anticonvulsants; Antidepressive Agents; Cyclohexanecarboxylic Acids; Cyclohexanols; Desipramine; Gabapentin; gamma-Aminobutyric Acid; Male; Mice; Mice, Transgenic; Morpholines; Pain; Pain Threshold; Propanolamines; Reboxetine; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-2; Sciatic Nerve; Venlafaxine Hydrochloride; Yohimbine | 2009 |
Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Anxiety Disorders; Confidence Intervals; Cost-Benefit Analysis; Cyclohexanols; Delayed-Action Preparations; Economics, Pharmaceutical; gamma-Aminobutyric Acid; Humans; Models, Economic; Models, Statistical; Monte Carlo Method; Pregabalin; Psychiatric Status Rating Scales; Psychometrics; Quality-Adjusted Life Years; Spain; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Teaching case: menopausal migraine.
Topics: Amines; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Fructose; Gabapentin; gamma-Aminobutyric Acid; Gonadal Steroid Hormones; Herbal Medicine; Hot Flashes; Humans; Menstrual Cycle; Menstruation Disturbances; Middle Aged; Migraine Disorders; Postmenopause; Topiramate; Venlafaxine Hydrochloride | 2010 |
The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Amines; Anti-Anxiety Agents; Breast Neoplasms; Clonidine; Cyclohexanecarboxylic Acids; Cyclohexanols; Fatigue; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Libido; Menopause; Middle Aged; Patient Care Team; Patient Education as Topic; Patient Satisfaction; Patient-Centered Care; Practice Guidelines as Topic; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Sweating; Sympatholytics; Venlafaxine Hydrochloride; Vitamin E; Vitamins | 2010 |
Parecoxib and its metabolite valdecoxib directly interact with cannabinoid binding sites in CB1-expressing HEK 293 cells and rat brain tissue.
Topics: Amino Acids; Animals; Binding, Competitive; Brain Chemistry; Cyclic AMP; Cyclohexanols; Cyclooxygenase 2 Inhibitors; gamma-Aminobutyric Acid; Glutamic Acid; Guanosine 5'-O-(3-Thiotriphosphate); HEK293 Cells; Humans; Isoxazoles; Male; Radioligand Assay; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Sulfonamides; Transfection | 2011 |
Pregabalin and topiramate regulate behavioural and brain gene transcription changes induced by spontaneous cannabinoid withdrawal in mice.
Topics: Analysis of Variance; Animals; Anticonvulsants; Anxiety; Behavior, Animal; Body Temperature; Cannabinoids; Cyclohexanols; Dose-Response Relationship, Drug; Drug Tolerance; Fructose; gamma-Aminobutyric Acid; Male; Marijuana Abuse; Mice; Models, Animal; Motor Activity; Nucleus Accumbens; Pregabalin; Receptor, Cannabinoid, CB1; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Topiramate; Transcription, Genetic; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2013 |
Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus.
Topics: Age Factors; Animals; Antidepressive Agents, Second-Generation; Corticosterone; Cyclohexanols; Depression; Excitatory Amino Acid Transporter 1; Female; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Glutamic Acid; Hippocampus; Male; Maternal Deprivation; Nerve Net; Neurons; Rats; Venlafaxine Hydrochloride | 2012 |
Sex-specific disturbances of the glutamate/GABA balance in the hippocampus of adult rats subjected to adolescent cannabinoid exposure.
Topics: Animals; Cannabinoids; Cyclohexanols; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Female; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Male; Microdialysis; Neurons; Rats; Rats, Wistar; Sex Factors; Synaptic Transmission | 2012 |
Endpoints of drug discovery for menopausal vasomotor symptoms: interpretation of data from a proxy of disease.
Topics: Acetamides; Amines; Animals; Body Temperature Regulation; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal; Diurnal Enuresis; Drug Discovery; Estradiol; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Hypnotics and Sedatives; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Skin Temperature; Venlafaxine Hydrochloride | 2012 |
Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission.
Topics: Animals; Anxiety; Behavior, Animal; Cannabinoids; Cyclohexanols; Cyclopentanes; Dose-Response Relationship, Drug; GABA Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Pyrimidines; Receptor, Cannabinoid, CB1; Receptors, GABA-B; Synaptic Transmission | 2012 |
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes.
Topics: Acetamides; Analysis of Variance; Animals; Antidepressive Agents; Calcium Ionophores; Cyclohexanols; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Ionomycin; Male; Potassium Chloride; Rats; Rats, Sprague-Dawley; SNARE Proteins; Synaptosomes; Syntaxin 1; Venlafaxine Hydrochloride | 2013 |